CT0590 CAR T Cells
CT0590-CG6012
Unknown mab active
Quick answer
CT0590 CAR T Cells for Relapsed and/or Refractory Multiple Myeloma is a Unknown program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Relapsed and/or Refractory Multiple Myeloma
- Phase
- Unknown
- Modality
- mab
- Status
- active